Cargando…

Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling

Antiviral drugs are of paramount importance in the accomplishment of the vision of zero new cases of COVID-19 globally, through sustainable retaliation against viral diseases. However, several challenges currently exist in Africa which include insufficient infrastructure, deteriorating health system...

Descripción completa

Detalles Bibliográficos
Autores principales: Rackimuthu, Sudhan, Kazmi, Zohra, Osman Elmahi, Osman Kamal, Hunain, Reem, Ghazi, Behram Khan, Zaidi, Zain Ali, Costa, Ana Carla dos Santos, Ahmad, Shoaib, Essar, Mohammad Yasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of Minnesota Libraries Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401371/
https://www.ncbi.nlm.nih.gov/pubmed/36033124
http://dx.doi.org/10.24926/iip.v12i4.4328
_version_ 1784772954188414976
author Rackimuthu, Sudhan
Kazmi, Zohra
Osman Elmahi, Osman Kamal
Hunain, Reem
Ghazi, Behram Khan
Zaidi, Zain Ali
Costa, Ana Carla dos Santos
Ahmad, Shoaib
Essar, Mohammad Yasir
author_facet Rackimuthu, Sudhan
Kazmi, Zohra
Osman Elmahi, Osman Kamal
Hunain, Reem
Ghazi, Behram Khan
Zaidi, Zain Ali
Costa, Ana Carla dos Santos
Ahmad, Shoaib
Essar, Mohammad Yasir
author_sort Rackimuthu, Sudhan
collection PubMed
description Antiviral drugs are of paramount importance in the accomplishment of the vision of zero new cases of COVID-19 globally, through sustainable retaliation against viral diseases. However, several challenges currently exist in Africa which include insufficient infrastructure, deteriorating health systems, and rising costs of healthcare delivery with concomitant rising inequity with regards to access to health services amid the COVID-19 pandemic. The pandemic itself has stimulated an increased use of phytotherapy in Africa as a result of essential drug shortages that have been attributed to a plethora of contributing factors such as travel restrictions, reduced per capita income as well as increased expenditure on transport. As a result, the paucity of antiviral along with antiretroviral drugs used to combat COVID-19 as well as several other endemic viral diseases in Africa has created a worrisome state. This article therefore discusses and aims to underscore the causes, effects, and implications of antiviral and antiretroviral shortages amid COVID-19 in Africa.
format Online
Article
Text
id pubmed-9401371
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher University of Minnesota Libraries Publishing
record_format MEDLINE/PubMed
spelling pubmed-94013712022-08-25 Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling Rackimuthu, Sudhan Kazmi, Zohra Osman Elmahi, Osman Kamal Hunain, Reem Ghazi, Behram Khan Zaidi, Zain Ali Costa, Ana Carla dos Santos Ahmad, Shoaib Essar, Mohammad Yasir Innov Pharm Commentary Antiviral drugs are of paramount importance in the accomplishment of the vision of zero new cases of COVID-19 globally, through sustainable retaliation against viral diseases. However, several challenges currently exist in Africa which include insufficient infrastructure, deteriorating health systems, and rising costs of healthcare delivery with concomitant rising inequity with regards to access to health services amid the COVID-19 pandemic. The pandemic itself has stimulated an increased use of phytotherapy in Africa as a result of essential drug shortages that have been attributed to a plethora of contributing factors such as travel restrictions, reduced per capita income as well as increased expenditure on transport. As a result, the paucity of antiviral along with antiretroviral drugs used to combat COVID-19 as well as several other endemic viral diseases in Africa has created a worrisome state. This article therefore discusses and aims to underscore the causes, effects, and implications of antiviral and antiretroviral shortages amid COVID-19 in Africa. University of Minnesota Libraries Publishing 2021-09-22 /pmc/articles/PMC9401371/ /pubmed/36033124 http://dx.doi.org/10.24926/iip.v12i4.4328 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Rackimuthu, Sudhan
Kazmi, Zohra
Osman Elmahi, Osman Kamal
Hunain, Reem
Ghazi, Behram Khan
Zaidi, Zain Ali
Costa, Ana Carla dos Santos
Ahmad, Shoaib
Essar, Mohammad Yasir
Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling
title Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling
title_full Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling
title_fullStr Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling
title_full_unstemmed Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling
title_short Antiviral and antiretroviral drug shortages amidst COVID-19: How Africa is struggling
title_sort antiviral and antiretroviral drug shortages amidst covid-19: how africa is struggling
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9401371/
https://www.ncbi.nlm.nih.gov/pubmed/36033124
http://dx.doi.org/10.24926/iip.v12i4.4328
work_keys_str_mv AT rackimuthusudhan antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling
AT kazmizohra antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling
AT osmanelmahiosmankamal antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling
AT hunainreem antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling
AT ghazibehramkhan antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling
AT zaidizainali antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling
AT costaanacarladossantos antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling
AT ahmadshoaib antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling
AT essarmohammadyasir antiviralandantiretroviraldrugshortagesamidstcovid19howafricaisstruggling